ANDA 90153, held by Actavis Labs Fl Inc. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 90153 (Zolpidem Tartrate), held by Actavis Labs Fl Inc, was first approved by FDA on Mar 25, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 25, 2013 | Original application | Approved | None posted |
| Zolpidem Tartrate6.25MG · tablet, extended release;oral | Zolpidem Tartrate | Discontinued |
| Zolpidem Tartrate12.5MG · tablet, extended release;oral | Zolpidem Tartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters